Biogen (BIIB)
NASDAQ:BIIB

Biogen (BIIB) Technical Analysis

4,062 Followers

Technical Sentiment

Overall Consensus
Strong Sell
1Bullish
6Neutral
15Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Biogen’s (BIIB) Moving Averages Convergence Divergence (MACD) indicator is -5.54, suggesting Biogen is a Sell.
Biogen’s (BIIB) 20-Day exponential moving average is 233.70, while Biogen’s (BIIB) share price is $232.06, making it a Sell.
Biogen’s (BIIB) 50-Day exponential moving average is 244.19, while Biogen’s (BIIB) share price is $232.06, making it a Sell.

Biogen (BIIB) Pivot Points

Nov 29, 2023, 10:47 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
221.34
224.22
226.50
229.38
231.66
234.54
236.82
Fibonacci
224.22
226.19
227.41
229.38
231.35
232.57
234.54
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biogen (BIIB) Moving Averages

Nov 29, 2023, 10:47 PM
Period
Simple
Exponential
MA5
229.79Sell
229.12Sell
MA10
229.14Sell
230.00Sell
MA20
232.90Sell
233.70Sell
MA50
247.17Sell
244.19Sell
MA100
257.58Sell
255.39Sell
MA200
272.63Sell
267.83Sell
Biogen’s (BIIB) 10-Day exponential moving average is 230.00, while Biogen’s (BIIB) share price is $232.06, making it a Sell.
Biogen’s (BIIB) 100-Day exponential moving average is 255.39, while Biogen’s (BIIB) share price is $232.06, making it a Sell.
Biogen’s (BIIB) stock price is $232.06 and Biogen’s (BIIB) 50-day simple moving average is 247.17, creating a Sell signal.
Biogen’s (BIIB) stock price is $232.06 and Biogen’s (BIIB) 100-day simple moving average is 257.58, creating a Sell signal.
Biogen’s (BIIB) stock price is $232.06 and Biogen’s (BIIB) 200-day simple moving average is 272.63, creating a Sell signal.

Biogen (BIIB) Technical Indicators

Nov 29, 2023, 10:47 PM
Name
Value
Implied Action
RSI (14)
36.86
Neutral
STOCH (9,6)
64.60
Neutral
STOCHRSI (14)
30.18
Neutral
MACD (12,26)
5.54
Sell
ADX (14)
27.04
Neutral
Williams %R
74.46
Buy
CCI (14)
68.21
Neutral
ATR (14)
5.30
-
Ultimate Oscillator
48.98
Neutral
ROC
7.41
Sell
Biogen’s (BIIB) Relative Strength Index (RSI) is 36.86, creating a Neutral signal.
Biogen’s (BIIB) Trend Strength Indicator (ADX) is 27.04, creating a Neutral signal.
Biogen’s (BIIB) Commodity Channel Index (CCI) is -68.21, creating a Neutral signal.
Biogen’s (BIIB) Price Rate of Change (ROC) is -7.41, creating a Sell signal.

FAQ

Is BIIB a Buy, Hold, or Sell?
Based on BIIB’s technical indicators, BIIB is a Strong Sell.
    What is BIIB’s RSI (14)?
    BIIB’s RSI (14) is 36.86, which suggests BIIB is a Neutral.
      What is BIIB’s MACD?
      BIIB’s MACD is -5.54, which suggests BIIB is a Sell.
        What is BIIB’s 5-day moving average?
        BIIB’s 5-day moving average is 229.79, which suggests BIIB is a Sell.
          What is BIIB’s 20-day moving average?
          BIIB 20-day moving average is 232.90, which suggests BIIB is a Sell.
            What is BIIB’s 50-day moving average?
            BIIB’s 50-day moving average is 247.17, which suggests BIIB is a Sell.
              What is BIIB’s 200-day moving average?
              BIIB’s 200-day moving average is 272.63, which suggests BIIB is a Sell.
                What is BIIB’s Williams % R (14)?
                BIIB’s Williams % R (14) is -74.46, which suggests BIIB is a Buy.
                  What is BIIB’s CCI (14)?
                  BIIB’s CCI (14) is -68.21, which suggests BIIB is a Neutral.

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis